Skip to main content
SpringerLink
Log in

Maligne Tumoren der Leber und Gallenwege

  • Chapter
Therapie von Leber- und Gallekrankheiten

Zusammenfassung

Maligne Tumoren der Leber können primär im Organ oder den topographisch zugeordneten Strukturen der Gallenwege entstehen oder sekundär als Metastasen von Tumoren anderer Organe die Leber befallen. Die Malignome der extrahepatischen Gallenwege (extrahepatische Gallengänge, Gallenblase, Papilla Vateri) werden wegen ihrer engen Beziehung zur Leber ebenfalls hier berücksichtigt. Komplikationen wie etwa eine Cholestase sind nicht selten Folge dieser formal extrahepatischen Prozesse.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215:31–38

    Article  PubMed  CAS  Google Scholar 

  • Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19:311–322

    Article  PubMed  CAS  Google Scholar 

  • Bobbio-Pallavicini E, Porta C, Moroni M, Bertulezzi G, Civelli L, Pugliese P, Nastasi G (1997) Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study. Eur J Cancer 33:1785–1788

    Article  Google Scholar 

  • Caselmann WH, Blum HE, Fleig WE, Huppert PE, Ramadori G, Schirmacher P, Sauerbruch T (1999) Leitlinien der Deutschen Gesellschaft für Verdauungs-und Stoffwechselkrankheiten zur Diagnostik und Therapie des hepatozellulären Karzinoms. Z Gastroenterol 37:353–365

    PubMed  CAS  Google Scholar 

  • Dienes HP (1998) Häufigkeit und Klassifikation von primären Lebertumoren. In: Deutsche Gesellschaft für Verdauungs-und Stoffwechselkrankheiten. Arbeitsgemeinschaft Gastroenterologische Onkologie. Lebertumore, Hannover. 16–20

    Google Scholar 

  • Dusheiko GM, Hobbs KEF, Dick R, Burroghs AK (1992) Treatment of small hepatocellular carcinomas. Lancet 340:285–288

    Article  PubMed  CAS  Google Scholar 

  • Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Eng J Med 341:1368–1378

    Article  Google Scholar 

  • Groupe d’etude et de traitment du carcinome hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261

    Article  Google Scholar 

  • Hermanek P, Sobin LH (Hrsg) (1992) UICC TNM classification of malignant tumors, 4th edn. Springer, Berlin

    Google Scholar 

  • Herrmann R, Orth B, Neuhaus P (1994) Gallenblasen-und Gallengangkarzinom. In: Wilmanns W, Huhn D, Wilms K (Hrsg) Internistische Onkologie. Thieme, Stuttgart New York, S 543–547

    Google Scholar 

  • Ishii H, Okada S, Okusaka T Yoshimori M, Nakasuka H, Shimada K, Yamasaki S, Nakanishi Y, Sakamato M (1998) Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 82:1638–42

    Article  PubMed  CAS  Google Scholar 

  • Koito K, Namieno T, Ichimura T, Hirokawa N, Syonai T, Hareyama M, Katsuramaki T, Hirata K, Nishi M (2000) Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with arterial embolization or percutaneous ethanol injection therapy. Am Roentgenol 174:337–41

    CAS  Google Scholar 

  • Kojiro M, Nakashima O (1999) Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 19:287–296

    Article  PubMed  CAS  Google Scholar 

  • Kudo M (1999) Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. Semin Liver Dis 19:297–309

    Article  PubMed  CAS  Google Scholar 

  • Lake JR (1993) Benign and malignant neoplasms of the gallbladder, bile ducts, and ampulla. In: Sleisenger MH, Fordtran JS (Hrsg) Gastrointestinal disease: pathophysiology, diagnosis, management, 5th edn. WB Saunders, Philadelphia, S 1891–1901

    Google Scholar 

  • Livraghi T, Giorgio A, Marin G, et al., (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101–108

    PubMed  CAS  Google Scholar 

  • Livraghi T, Goldberg SN, Lazzaroni S (1999) Radiofrequency ablation vs. ethanol injection in the treatment of small hepatocellular carcinoma. Radiology 210:655–661

    PubMed  CAS  Google Scholar 

  • Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semi Liver Dis 19:329–338

    Article  CAS  Google Scholar 

  • Lorenz M, Liermann D, Staib-Sebler E, Gog C, Encke A, Kollath J (1994) Noradrenalingestützte selektive Chemoembolisation von hepatozellulären Karzinomen. Zentralbl Chir 119:777–786

    PubMed  CAS  Google Scholar 

  • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699

    Article  PubMed  CAS  Google Scholar 

  • Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, Tanaka T, Tsurumi K, Okuno M, Tomita E, Nakamura T, Kojima T (1996) Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Engl J Med 334:1561–1567

    Article  PubMed  CAS  Google Scholar 

  • Okada S (1999) Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis 19:323–328

    Article  PubMed  CAS  Google Scholar 

  • Okuda K, Ohtuiki T, Obata H, et al. (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56:918

    Article  PubMed  CAS  Google Scholar 

  • Okuda K, Kojiro M, Okuda H (1993) Neoplasms of the liver. In: Schiff L, Schiff ER (Hrsg) Diseases of the liver, 7th edn. JB Lippincott, Philadelphia, S 1236–1296

    Google Scholar 

  • Onishi K, Yoshioka H, Ito S, Fujiwara K (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:67–72

    Article  Google Scholar 

  • Ormann, W (1993) Das fibrolamelläre hepatozelluläre Karzinom. Leber Magen Darm 23:128–131

    PubMed  CAS  Google Scholar 

  • Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, Müller JM, Hortnagl H, Lochs H (1998) Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114:536–542

    Article  PubMed  CAS  Google Scholar 

  • Petry W, Heintges T, Hensel F, Erhardt A, Wenning M, Niederau C, Häussinger D (1997) Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic. Z Gastroenterol 35:1059–1067

    PubMed  CAS  Google Scholar 

  • Scheithauer W, Heijna M (1995) Hepatocellular carcinoma. Oncology 18:327–332

    Article  Google Scholar 

  • Tsukuma H, Hiyama T, Tanaka S, et al., (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797–1801

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. W. Sahm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Lorenz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Schwerpunkt Gastroenterologie, Direktor der Medizinischen Klinik II, Zentrum der Inneren Medizin, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany

    W. F. Caspary

  2. Schwerpunkt Gastroenterologie, Medizinische Klinik II, Zentrum der Inneren Medizin, Universitätsklinikum Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany

    U. Leuschner  & S. Zeuzem  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sahm, S.W., Lorenz, M. (2001). Maligne Tumoren der Leber und Gallenwege. In: Caspary, W.F., Leuschner, U., Zeuzem, S. (eds) Therapie von Leber- und Gallekrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56819-0_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56819-0_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63151-1

  • Online ISBN: 978-3-642-56819-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation